Interestingly, by combining GLP-1 and GIP agonism into a single molecule, the GIP/GLP-1 coagonist has enhanced therapeutic properties to improve glucose tolerance and induce weight loss, which was demonstrated in rodents, non-human primates and humans (Finan et al., 2013)
This longer timeline usually responds well to fiber supplements, magnesium citrate, and increased water intake rather than dose reduction
Products marketed for this purpose lack scientific support
Huayu Yang, [email protected] These authors have contributed equally to this work This article was submitted to Nutrition and Metabolism, a section of the journal Frontiers in Nutrition Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Lilly reported that some TRIUMPH-4 dropouts were people losing more weight than they wanted, rather than people stopping due to side effects
Registered dietitian Ashley Koff highlights another important consideration: nutrient quality